Australian medical device leader Cochlear Ltd. saw its stock price collapse after slashing fiscal year profit expectations. The sell-off represents the company's steepest single-day decline since its 1995 public debut.
- Shares plummeted as much as 39% in early Sydney trading
- Worst single-day performance since the company's 1995 IPO
- Decline triggered by a cut in fiscal year profit guidance
- Historic volatility for the Australian medical device firm
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.